Chapter title |
Community-Associated Methicillin-Resistant Staphylococcus aureus Case Studies.
|
---|---|
Chapter number | 2 |
Book title |
Methicillin-Resistant Staphylococcus Aureus (MRSA) Protocols
|
Published in |
Methods in molecular biology, January 2014
|
DOI | 10.1007/978-1-62703-664-1_2 |
Pubmed ID | |
Book ISBNs |
978-1-62703-663-4, 978-1-62703-664-1
|
Authors |
Madeleine G Sowash, Anne-Catrin Uhlemann, Madeleine G. Sowash, Sowash, Madeleine G., Uhlemann, Anne-Catrin |
Abstract |
Over the past decade, the emergence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has changed the landscape of S. aureus infections around the globe. Initially recognized for its ability to cause disease in young and healthy individuals without healthcare exposures as well as for its distinct genotype and phenotype, this original description no longer fully encompasses the diversity of CA-MRSA as it continues to expand its niche. Using four case studies, we highlight a wide range of the clinical presentations and challenges of CA-MRSA. Based on these cases we further explore the globally polygenetic background of CA-MRSA with a special emphasis on generally less characterized populations. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 1% |
Germany | 1 | <1% |
United Kingdom | 1 | <1% |
Malaysia | 1 | <1% |
Denmark | 1 | <1% |
Canada | 1 | <1% |
Unknown | 165 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 33 | 19% |
Researcher | 27 | 16% |
Student > Master | 25 | 15% |
Student > Ph. D. Student | 16 | 9% |
Student > Doctoral Student | 11 | 6% |
Other | 32 | 19% |
Unknown | 28 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 45 | 26% |
Agricultural and Biological Sciences | 30 | 17% |
Immunology and Microbiology | 17 | 10% |
Biochemistry, Genetics and Molecular Biology | 14 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 5% |
Other | 20 | 12% |
Unknown | 38 | 22% |